Royal Cornwall Hospitalsnhs Trust

Truro TR1 3LQ

3 studies enrolling now · 7 studies all time

What they study most

Acute Myeloid Leukemia, Acute Myocardial Infarction, Advanced Malignancies, Chronic Lymphocytic Leukemia, Chronic Myelomonocytic Leukemia, Coronary Artery Disease, HER2 Positive Breast Cancer, Myelodysplastic Syndromes, NSCLC, Ovarian Cancer, Parkinson´s Disease, Relapsed/Refractory AML

Studies at this site

• A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma — Recruiting now
• A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) — Recruiting now
• Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease — Recruiting now
• Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing — Running, not enrolling
• A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies — Running, not enrolling
• Rostock International Parkinson's Disease Study (ROPAD) — Completed
• A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer — Completed